Creo Medical Group PLC (AIM:CREO) has announced the retirement of John Bradshaw from the board.
Bradshaw has served as senior independent non-executive director since the company’s IPO in 2016. The departure is effective immediately.
"I would like to thank John for his service to the company,” said executive chair Kevin Crofton.
“John has helped guide and lead Creo with professionalism and pragmatism during his nine-year tenure from IPO, and has provided much welcome support to me and the team as we've continued to build the Company's governance framework."